1st Quarter - Report
BROWNSTEIN HYATT FARBER SCHRECK, LLP for NOVARTIS
Client
Income
$60,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to cell and gene therapy Pharmaceutical pricing Issues related to the development of therapies for rare diseases, Issues related to COVID-19 340B Drug Discount Program Supply chain issues affecting pharmaceutical products Inflation reduction Act Pharmaceutical innovation PBM policy issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURA JOHNSON BOLLIER | — |
| NADEAM ELSHAMI | — |
| EMILY FELDER | — |
| MARC LAMPKIN | — |
| BRIAN THOMAS MCGUIRE | — |
| ZACHARY PFISTER | — |
| ADAM STEINMETZ | — |
| BRIAN WILD | — |
Veterans VET
Opportunities for health care collaboration Issues related to Medicare and Medicaid for Veterans
| Lobbyist | Covered position, as disclosed |
|---|---|
| NADEAM ELSHAMI | — |
| MARC LAMPKIN | — |
| ZACHARY PFISTER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.